4.6 Article

Identification of the Key Differential Transcriptional Responses of Human Whole Blood Following TLR2 or TLR4 Ligation In-Vitro

Journal

PLOS ONE
Volume 9, Issue 5, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0097702

Keywords

-

Funding

  1. Medical Research Council, United Kingdom [U117565642]
  2. MRC Clinical Research Training Fellowship
  3. MRC [MC_U117565642] Funding Source: UKRI
  4. Medical Research Council [MC_U117565642] Funding Source: researchfish

Ask authors/readers for more resources

The use of human whole blood for transcriptomic analysis has potential advantages over the use of isolated immune cells for studying the transcriptional response to pathogens and their products. Whole blood stimulation can be carried out in a laboratory without the expertise or equipment to isolate immune cells from blood, with the added advantage of being able to undertake experiments using very small volumes of blood. Toll like receptors (TLRs) are a family of pattern recognition receptors which recognise highly conserved microbial products. Using the TLR2 ligand (Pam3CSK4) and the TLR4 ligand (LPS), human whole blood was stimulated for 0, 1, 3, 6, 12 or 24 hours at which times mRNA was isolated and a comparative microarray was undertaken. A common NF kappa B transcriptional programme was identified following both TLR2 and TLR4 ligation which peaked at between 3 to 6 hours including upregulation of many of the NFkB family members. In contrast an interferon transcriptional response was observed following TLR4 but not TLR2 ligation as early as 1 hour post stimulation and peaking at 6 hours. These results recapitulate the findings observed in previously published studies using isolated murine and human myeloid cells indicating that in vitro stimulated human whole blood can be used to interrogate the early transcriptional kinetic response of innate cells to TLR ligands. Our study demonstrates that a transcriptomic analysis of mRNA isolated from human whole blood can delineate both the temporal response and the key transcriptional differences following TLR2 and TLR4 ligation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Respiratory System

Treatment Transitions in Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases

Chloe Bloom, Jukka Montonen, Olaf Jons, Elizabeth M. Garry, Surya P. Bhatt

Summary: This study aimed to investigate treatment switching patterns from first to second maintenance therapy among COPD patients in the US and UK. Results showed that the proportion of patients prescribed inhaled corticosteroids (ICS) was higher than expected based on guidelines in both countries.

PULMONARY THERAPY (2022)

Article Critical Care Medicine

Susceptibility of Patients with Airway Disease to SARS-CoV-2 Infection

Francesca M. Conway, Chloe Bloom, Pallav L. Shah

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Critical Care Medicine

Forgiveness Is the Attribute of the Strong: Nonadherence and Regimen Shortening in Drug-sensitive Tuberculosis

Helen R. Stagg, Jennifer A. Thompson, Marc C. Lipman, Derek J. Sloan, Mary Flook, Katherine L. Fielding

Summary: This study aimed to determine the impact of regimen length, drugs, dosing, and nonadherence timing on the forgiveness of antituberculosis regimens. The results showed that shorter 4-month regimens were just as forgiving as the standard 6-month regimen and did not differ in terms of nonadherence tolerance. The study also found evidence of mediation by continuation phase dose-taking on the relationship between intensive phase dose-taking and negative outcome.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Pharmacology & Pharmacy

Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trials

Akosua A. Agyeman, Tao You, Phylinda L. S. Chan, Dagan O. Lonsdale, Christoforos Hadjichrysanthou, Tabitha Mahungu, Emmanuel Q. Wey, David M. Lowe, Marc C. Lipman, Judy Breuer, Frank Kloprogge, Joseph F. Standing

Summary: Pharmacometric analyses of time series viral load data have greater power in detecting drug effects compared to single time point approaches. In analyzing Phase II-type viral dynamic data, different modeling approaches were compared. The study found that simple models should be considered for pharmacodynamic model development when analyzing viral dynamic data.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Letter Infectious Diseases

Cutaneous adverse drug reactions to fixed-dose combination treatments for TB

E. McCormick, J. Brown, J. Barrett, C. Campbell, D. Creer, I. Cropley, D. Lowe, R. Moores, M. Lipman

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2022)

Article Medicine, General & Internal

Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial

Molebogeng X. Rangaka, Yohhei Hamada, Trinh Duong, Henry Bern, Joanna Calvert, Marie Francis, Amy Louise Clarke, Alex Ghanouni, Charlotte Layton, Vanessa Hack, Ellen Owen-Powell, Julian Surey, Karen Sanders, Helen L. Booth, Angela Crook, Chris Griffiths, Robert Horne, Heinke Kunst, Marc Lipman, Mike Mandelbaum, Peter J. White, Dominik Zenner, Ibrahim Abubakar

Summary: This study aims to evaluate the effect of novel short-course rifapentine-based regimens for TB prevention and additional theory-based treatment support on treatment adherence. The study will recruit participants aged 16 to 65 who are eligible to start TB preventive therapy and will conduct a randomized controlled trial to assess the outcomes.

BMJ OPEN (2022)

Review Respiratory System

Covid-19 pandemic and asthma: What did we learn?

Chloe I. Bloom

Summary: This review summarizes the major lessons learned about asthma and the covid-19 pandemic, including susceptibility to SARS-CoV-2 infection and severe covid-19, potential protective factors, comparison to other respiratory infections, changes in healthcare behavior from the perspective of patients and clinicians, medications for treating or preventing covid-19, and post-covid syndrome.

RESPIROLOGY (2023)

Correction Multidisciplinary Sciences

Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea (vol 12, 12362, 2022)

Hyung Woo Kim, Sohee Park, Jinsoo Min, Jiyu Sun, Ah Young Shin, Jick Hwan Ha, Jae Seuk Park, Sung-Soon Lee, Marc Lipman, Ibrahim Abubakar, Helen R. Stagg, Ju Sang Kim

SCIENTIFIC REPORTS (2023)

Review Microbiology

The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease

Meyad Alkarni, Marc Lipman, David M. Lowe

Summary: Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) is a global health issue. Neutrophils are found to have a dual role in NTM infection: controlling the infection in the early phase but also contributing to disease progression. Understanding the roles of neutrophils in NTM-PD is crucial for developing preventive strategies and host-directed therapy.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2023)

Article Immunology

Changes in short-term (in-ICU and in-hospital) mortality following intensive care unit admission in adults living with HIV: 2000-2019

Tanmay Kanitkar, Oshani Dissanayake, Nicholas Bakewell, Maggie Symonds, Stephanie Rimmer, Amit Adlakha, Marc C. I. Lipman, Sanjay Bhagani, Caroline A. Sabin, Banwari Agarwal, Robert F. Miller

Summary: This study investigated the trend of in-ICU/in-hospital mortality among people with HIV admitted to ICU in a UK-based HIV referral centre from 2000 to 2019. The results showed a decreasing trend in mortality rates over time.
Editorial Material Critical Care Medicine

CC16: A Treatable Trait in Asthma?

Chloe I. Bloom, Ian M. Adcock

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Letter Infectious Diseases

Impact of COVID-19 on NHS tuberculosis services: Results of a UK-wide survey

Hazel Morrison, Felicity Perrin, Martin Dedicoat, Rizwan Ahmed, James Brown, Maria Loughenbury, Suman Paul, Miguel Souto, Richard Ward, Marc Lipman

JOURNAL OF INFECTION (2023)

Article Medicine, General & Internal

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial

Pratima Chowdary, Banwari Agarwal, Maria Rita Peralta, Sanjay Bhagani, Simon Lee, James Goldring, Marc Lipman, Emal Waqif, Mark Phillips, Helen Philippou, Jonathan H. Foley, Nicola J. Mutch, Robert A. S. Ariens, Kathleen A. Stringer, Federico Ricciardi, Marie Watissee, Derralynn Hughes, Amit Nathwani, Anne Riddell, David Patch, Jim Buckley, Mark De Neef, Rahul Dimber, Cecilia Diaz-Garcia, Honey Patel, Aarti Nandani, Upuli Dissanayake, Nick Chadwick, Ahmed A. A. M. M. Alkhatip, Peter Watkinson, Eamon Raith, Suveer Singh, Tony Wolff, Rajeev Jha, Simon E. Brill, Ameet Bakhai, Alison Evans, Farhat Gilani, Keith Gomez

Summary: Nebulized recombinant tissue plasminogen activator (rt-PA) has the potential to improve lung injury and oxygenation in COVID-19 patients. Preliminary studies show better outcomes in patients receiving non-invasive respiratory support (NIRS). Randomized clinical trials are needed to confirm the clinical effects.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Respiratory System

Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review

Chris Wai Hang Lo, Swathi Pathadka, Simon Xiwen Qin, Lydia W. Y. Fung, Vincent Ka Chun Yan, Hei Hang Edmund Yiu, Chloe I. Bloom, Ian Chi Kei Wong, Esther Wai Yin Chan

Summary: This study systematically reviewed the neuropsychiatric events associated with montelukast, finding no significant association with suicide and depression events in asthma patients, but possible associations with anxiety and sleeping disorders, particularly in older adults.

EUROPEAN RESPIRATORY REVIEW (2023)

Article Immunology

Host-directed immunotherapy of viral and bacterial infections: past, present and future

Robert S. Wallis, Anne O'Garra, Alan Sher, Andreas Wack

Summary: This Perspective reflects on the historical development of host-directed immunotherapeutic interventions for viral and bacterial infections, and discusses their application to current approaches to therapy of SARS-CoV-2 and Mycobacterium tuberculosis infections.

NATURE REVIEWS IMMUNOLOGY (2023)

No Data Available